PLATINUM QCA: a prospective, multicentre study assessing clinical, angiographic, and intravascular ultrasound outcomes with the novel platinum chromium thin-strut PROMUS Element everolimus-eluting stent in de novo coronary stenoses

Ian T. Meredith1*, MBBS, PhD; Robert Whitbourn2, MBBS; Douglas Scott3, MBChB; Seif El-Jack4, MD; Robaayah Zambahari5, MD; Gregg W. Stone6, MD; Paul S. Teirstein7, MD; Ruth M. Starzyk8, PhD; Dominic J. Allocco8, MD; Keith D. Dawkins8, MD

1. MonashHEART, Southern Health, Monash Medical Centre, Clayton, Victoria, Australia; 2. St. Vincent’s Hospital, Fitzroy, Victoria, Australia; 3. Middlemore Hospital, Centre for Clinical Research and Effective Practice, Otahuh

Aims: Assess clinical, angiographic, and intravascular ultrasound results in lesions treated with the PROMUS Element platinum chromium everolimus-eluting stent (EES).

Sign in to read and download the full article

Login Forgot your password?

No account yet?
Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

coronary artery diseaseintravascular ultrasoundpromus elementquantitative coronary angiographyrestenosis

Share via Facebook Share via Twitter Share via LinkedIn Share by email

Read next article

Impact of transradial and transfemoral coronary interventions on bleeding and net adverse clinical events in acute coronary syndromes